BlueClinical Phase I
Porto, Portugal
Consultant in Porto
Ala Leste, Hospital da Prelada, Piso 3 e, Rua de Sarmento de Beires 153 do Piso 4, 4250-449 Porto
About BlueClinical Phase I
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Achieve Life Sciences
2
BAR Pharmaceuticals s.r.l.
1
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd
1
Clinical Trials at BlueClinical Phase I
During the past decade, BlueClinical Phase I conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX
2021-06-28
2021-10-19
Completed
32
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects
2022-11-25
2023-03-30
Not yet recruiting
32
Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers
2022-10-17
2022-12-23
Completed
27
Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose
2023-01-10
2023-06-01
Recruiting
56
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at BlueClinical Phase I
According to Clinical.Site data, the most researched conditions in "BlueClinical Phase I" are
"Non-Alcoholic Fatty Liver Disease" (1 trials), "Renal Impairment" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Smoking Cessation" (1 trials). Many other conditions were trialed in "BlueClinical Phase I" in a lesser frequency.
Clinical Trials Intervention Types at BlueClinical Phase I
Most popular intervention types in "BlueClinical Phase I" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BAR502" (1 trials), "Cytisinicline" (1 trials), "FBL-MTX" (1 trials) and "Moxifloxacin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at BlueClinical Phase I
The vast majority of trials in "BlueClinical Phase I" are
4 trials for "All" genders.
Clinical Trials Status at BlueClinical Phase I
Currently, there are NaN active trials in "BlueClinical Phase I".
1 are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in BlueClinical Phase I,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in BlueClinical Phase I, 4 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".